Agoraphobia
Methodology & AI Transparency ⓘ
Agoraphobia Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: For patients presenting with Agoraphobia (ICD-10-CM F40.00), Anxiety, OCD & Trauma Disorders protocols prioritize cognitive-behavioral exposure readiness in Agoraphobia (F40.00: evaluation) paired with baseline and interval GAD-7 Anxiety Severity in Agoraphobia (F40.00: Score) assessment.
- 2 Real-world patient consensus: Federal ICD-10-CM code F40.00 categorizes Agoraphobia under Anxiety, OCD & Trauma Disorders.
- 3 Typical cash cost range: Differential triage of Agoraphobia (F40.00) utilizes cognitive-behavioral exposure readiness in Agoraphobia (F40.00: evaluation).
- 4 Top reported side effects / signs: Objective lab/clinical target for Agoraphobia: GAD-7 Anxiety Severity in Agoraphobia (F40.00: Score) (< 4 (minimal anxiety) (F40.00)) and Resting Heart Rate in Agoraphobia (F40.00: Variability (HRV)).
Ask our AI Specialists anything about Agoraphobia
What Is Agoraphobia?
For patients presenting with Agoraphobia (ICD-10-CM F40.00), Anxiety, OCD & Trauma Disorders protocols prioritize cognitive-behavioral exposure readiness in Agoraphobia (F40.00: evaluation) paired with baseline and interval GAD-7 Anxiety Severity in Agoraphobia (F40.00: Score) assessment.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Agoraphobia (ICD-10 F40.00) is driven by amygdala threat-circuit hyperreactivity [Agoraphobia F40.00]; specialists in Anxiety, OCD & Trauma Disorders monitor Resting Heart Rate in Agoraphobia (F40.00: Variability (HRV)) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Agoraphobia (F40.00): excessive, hard-to-control anticipatory in Agoraphobia (F40.00: worry or intrusive)
- • Secondary Agoraphobia clinical sign: sudden autonomic surges in Agoraphobia (F40.00: with racing heart,)
- • Symptom flares in Agoraphobia correlating with GAD-7 Anxiety Severity in Agoraphobia (F40.00: Score) deviation outside < 4 (minimal anxiety) (F40.00)
- • Functional anxiety & ptsd impact requiring cognitive-behavioral exposure readiness in Agoraphobia (F40.00: evaluation) evaluation (F40.00)
Agoraphobia Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F40.00 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Anxiety, OCD & Trauma Disorders | NLM Clinical Tables |
| Diagnostic / Lab Marker: GAD-7 Anxiety Severity in Agoraphobia (F40.00: Score) | < 4 (minimal anxiety) (F40.00) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Resting Heart Rate in Agoraphobia (F40.00: Variability (HRV)) | Stable upward personal trend (F40.00) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: TSH & Ferritin in Agoraphobia (F40.00: Rule-Out) | TSH 0.8–2.5 mIU/L; Ferritin > 50 ng/mL (F40.00) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Agoraphobia
Treatment selection for Agoraphobia depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Agoraphobia)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Cognitive behavioral therapy, sertraline, or a combination in childhood: What a 488-Participant Study Found Both cognitive behavioral therapy and sertraline reduced the severity of anxiety in children with anxiety; a combination of the two therapies had a superior response rate. The New England journal of medicine • 2008-12-25 • Randomized Controlled Trial | N = 488 | 93/100 | PMID 18974308 ↗ |
| What the Latest Evidence Really Says About Drug treatment for panic disorder with or without agoraphobia: systematic review The findings suggest that SSRIs provide high rates of full symptom relief with low risk of side effects for the treatment of panic disorder. BMJ (Clinical research ed.) • 2022-01-19 • Meta-Analysis | Multi-cohort | 92/100 | PMID 35045991 ↗ |
| Can This Approach Help? Inside the Latest Research on Instructed increase in fear activation during exposure exercises does not enhance At the follow-up assessment, both treatment variants were equally effective in all outcomes. Behaviour research and therapy • 2026-02-15 • Phase III Randomized Trial | N = 124 | 82/100 | PMID 41539132 ↗ |
Agoraphobia Patient Community & “People Like Me” Threads
Filter Agoraphobia community threads and patient logs by age, biological sex, dosage, and treatment duration.